CLINICAL TRIAL / NCT05983770
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
- Interventional
- Active
- NCT05983770
AT-1501-K207: BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
This study will evaluate the safety and efficacy of AT-1501 compared with tacrolimus in patients undergoing kidney transplantation.